Cyclophosphamide: Time to Say Goodnight and Goodbye?
Journal:
Current Rheumatology Reviews
Volume:
1
Page:
189-191
Author(s):
Catherine Edwards and David Isenberg
Strategies for the Design of Potent and Selective Kinase Inhibitors
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
1845-1863
Author(s):
Campbell McInnes and Peter M. Fischer
Editorial [Hot Topic: ErbB Family and Downstream Signal Transduction Pathways as Targets for Anticancer Therapy (Guest Editor: F. Caponigro)]
Journal:
Current Drug Targets
Volume:
6
Page:
241-242
Author(s):
F. Caponigro
Drugging Cell Cycle Kinases in Cancer Therapy
Journal:
Current Drug Targets
Volume:
6
Page:
325-335
Author(s):
S. Blagden and J. de Bono
Multiple-Target Drugs: Inhibitors of Heat Shock Protein 90 and of Histone Deacetylase
Journal:
Current Drug Targets
Volume:
6
Page:
337-351
Author(s):
A. Budillon, F. Bruzzese, E. Di Gennaro and M. Caraglia
Improving the Targeting of Tubulin-Binding Agents: Lessons from Drug Resistance Studies
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
1719-1733
Author(s):
N. M. Verrills and M. Kavallaris
Synthesis and Biological Evaluation of 2-, 3-, and 4-Acylaminocinnamyl-Nhydroxyamides as Novel Synthetic HDAC Inhibitors
Journal:
Medicinal Chemistry
Volume:
1
Page:
245-254
Author(s):
A. Mai, S. Massa, R. Pezzi, S. Valente, P. Loidl and G. Brosch
Multi-Nuclear Platinum Drugs: A New Paradigm in Chemotherapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
5
Page:
267-279
Author(s):
Nial J. Wheate and J. Grant Collins
Pathophysiology of Blood-Spinal Cord Barrier in Traumatic Injury and Repair
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
1353-1389
Author(s):
Hari Shanker Sharma
Plasticity and Therapeutic Potential of Mesenchymal Stem Cells in the Nervous System
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
1255-1265
Author(s):
Donald G. Phinney and Iryna Isakova